All terms in BAO
| Label | Id | Description |
|---|---|---|
| acyl-CoA:cholesterol acyltransferase 2 inhibitor | CHEBI_64697 | |
| EC 2.3.1.26 (sterol O-acyltransferase) inhibitor | CHEBI_64696 | |
| neuromuscular agent | CHEBI_51372 | |
| Crimean-Congo hemorrhagic fever | DOID_12287 | [A viral infectious disease that is a hemorrhagic fever, has_material_basis_in Crimean-Congo hemorrhagic fever virus, which is transmitted_by Hyalomma ticks. The infection has_symptom headache, has_symptom high fever, has_symptom back pain, has_symptom joint pain, has_symptom stomach pain, has_symptom vomiting, has_symptom red eyes, has_symptom flushed face, has_symptom red throat, has_symptom petechiae (red spots) on the palate, has_symptom jaundice, has_symptom nosebleeds, and has_symptom blood in the feces and urine.] |
| GABA agent | CHEBI_51374 | |
| testicular leukemia | DOID_12286 | |
| muscle relaxant | CHEBI_51371 | |
| chronic lymphocytic leukemia | DOID_1040 | [A lymphoblastic leukemia characterized by over production of B-cells and their accumulation in bone marrow and blood.] |
| hereditary elliptocytosis | DOID_2373 | [A hematopoietic system disease characterized by oval or elliptical red blood cells, slight or absent hemolysis with little or no anemia; splenomegaly is often present.] |
| multiple sclerosis | DOID_2377 | [A demyelinating disease that involves damage to the fatty myelin sheaths around the axons of the brain and spinal cord resulting in demyelination and scarring.] |
| sterol demethylation inhibitor | CHEBI_83734 | |
| Vogt-Koyanagi-Harada disease | DOID_12297 | [A hypersensitivity reaction type II disease that is caused by T helper cell mediated autoimmune attack of melanocytes resulting in inflammation of the inside of the eye, whitening of hair, skin pigment loss, and meningitis.] |
| intellectual disability | DOID_1059 | [A specific developmental disorder that involves significant limitations both in mental functioning and in adaptive behavior such as communicating, taking care of him or herself, and social skills.] |
| oculocerebrorenal syndrome | DOID_1056 | |
| EC 1.8.1.9 (thioredoxin reductase) inhibitor | CHEBI_64670 | |
| EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD(+) or NADP(+) as acceptor) inhibitor | CHEBI_76869 | |
| kernicterus | DOID_2382 | [A brain disease that is characterized by hyperbilirubinemia-induced brain dysfunction.] |
| neonatal jaundice | DOID_2383 | [A pigmentation disease characterized by a high level of bilirubin in the blood, causing a yellowing of the skin and other tissues of a newborn infant.] |
| Wernicke encephalopathy | DOID_2384 | [A brain disease that is characterised by the presence of neurological symptoms of ophthalmoplegia, ataxia, and confusion caused by biochemical lesions of the central nervous system after exhaustion of B-vitamin reserves, in particular thiamine (vitamin B1).] |
| renal artery disease | DOID_2388 |